...
首页> 外文期刊>Journal of cataract and refractive surgery >Intrastromal corneal ring segments and posterior chamber phakic intraocular lens implantation for keratoconus correction.
【24h】

Intrastromal corneal ring segments and posterior chamber phakic intraocular lens implantation for keratoconus correction.

机译:基质内角膜环节段和后房有晶状体人工晶状体植入术用于圆锥角膜矫正。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

PURPOSE: To evaluate the efficacy, safety, and predictability of sequential implantation of Keraring intrastromal corneal ring segments (ICRS) and an Implantable Collamer Lens phakic intraocular lens (pIOL) with corneal relaxing incisions for refractive correction of keratoconus. SETTING: Fernandez-Vega Ophthalmological Institute, Oviedo, Spain. DESIGN: Cohort study. METHODS: This study comprised patients with keratoconus who had ICRS implantation followed 6 months later by pIOL implantation with corneal relaxing incisions. The uncorrected (UDVA) and corrected (CDVA) distance visual acuities and residual refractive errors, analyzed using vector analysis, were recorded preoperatively, 6 months after ICRS implantation, and 6 months after pIOL implantation. RESULTS: The study enrolled 40 eyes (31 patients). The mean UDVA (decimal) was 0.11 Snellen +/- 0.05 (SD) preoperatively, 0.18 +/- 0.14 Snellen 6 months after ICRS implantation (P=.001), and 0.50 +/- 0.27 Snellen 6 months after pIOL implantation (P<.0001). The mean CDVA was 0.56 +/- 0.23 Snellen, 0.68 +/- 0.25 Snellen, and 0.73 +/- 0.20 Snellen, respectively (all P<.0001). Six months after pIOL implantation, the efficacy index was 0.88 and the safety index, 1.28. At 6 months, 65% of eyes were within +/-1.00 diopter (D) of the desired refraction and 45% were within +/-0.50 D. The mean spherical equivalent after pIOL implantation was -1.19 +/- 1.33 D. CONCLUSION: Sequential ICRS and pIOL implantation plus corneal relaxing incisions provided good visual and refractive outcomes, indicating that it is a predictable procedure for refractive correction of keratoconus. FINANCIAL DISCLOSURE: No author has a financial or proprietary interest in any material or method mentioned.
机译:目的:评估Keraring基质内角膜环节段(ICRS)和植入式角膜晶状体晶状体人工晶状体(pIOL)与角膜松弛切口相继植入以矫正圆锥角膜的疗效,安全性和可预测性。地点:西班牙奥维耶多的费尔南德斯·维加眼科研究所。设计:队列研究。方法:本研究包括圆锥角膜患者,他们接受了ICRS植入,随后6个月后进行了pIOL植入和角膜松弛切口。术前,ICRS植入后6个月和pIOL植入后6个月记录使用矢量分析法分析的未矫正(UDVA)和矫正(CDVA)远视力和残余屈光不正。结果:该研究招募了40只眼(31例患者)。术前平均UDVA(十进制)为0.11 Snellen +/- 0.05(SD),植入ICRS后6个月为0.18 +/- 0.14 Snellen(P = .001),以及pIOL植入后6个月为0.50 +/- 0.27 Snellen(P <.0001)。平均CDVA分别为0.56 +/- 0.23 Snellen,0.68 +/- 0.25 Snellen和0.73 +/- 0.20 Snellen(所有P <.0001)。植入pIOL六个月后,功效指数为0.88,安全指数为1.28。在第6个月时,有65%的眼睛在所需屈光度的+/- 1.00屈光度(D)内,有45%的眼睛在+/- 0.50 D的屈光度内。pIOL植入后的平均球镜当量为-1.19 +/- 1.33D。 :顺序的ICRS和pIOL植入以及角膜松弛切口可提供良好的视觉和屈光效果,表明这是圆锥角膜屈光矫正的可预测程序。财务披露:没有任何作者对所提及的任何材料或方法有财务或所有权利益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号